Try our beta test site
954 studies found for:    Pulmonary Disease, Chronic Obstructive: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Pulmonary Disease, Chronic Obstructive: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Spontaneous Breathing Trials Using Pressure-Support or T-Tube in Chronic Obstructive Pulmonary Disease Patients Weaning Mechanical Ventilation
Conditions: Weaning of Mechanical Ventilation;   Chronic Obstructive Pulmonary Disease
Interventions: Procedure: "T" Tube Spontaneous Breathing Trial;   Procedure: Pressure Support Ventilation
2 Completed The Chronic Obstructive Pulmonary Disease Fish Oil Pilot Trial
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Dietary Supplement: n-3 polyunsaturated fatty acids;   Other: Placebo
3 Completed Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Aclidinium bromide;   Drug: Placebo Tiotropium;   Drug: Tiotropium;   Drug: Placebo LAS34273
4 Terminated
Has Results
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD
Conditions: Diabetes Mellitus;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: Subcutaneous Insulin;   Drug: Inhaled Insulin
5 Completed
Has Results
24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719/GW642444 125/25;   Drug: GSK573719/GW642444 62.5/25;   Drug: GW642444;   Drug: tiotropium bromide
6 Completed
Has Results
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: GSK573719/GW642444 125/25;   Drug: GSK573719/GW642444 62.5/25;   Drug: GSK573719;   Drug: tiotropium bromide
7 Completed A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).
Conditions: COPD;   Pulmonary Disease, Chronic Obstructive
Intervention: Drug: Collection of safety data for Cohort 1
8 Completed
Has Results
TOPIC Trial for COPD
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Ivacaftor;   Drug: Placebo
9 Recruiting Tele-spirometry in Primary Care-Randomized Clinical Trial Cluster:Telemedicine in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Other: Spirometry;   Other: telemonitoring;   Other: teleconsultation;   Other: Spirometry - 20 weeks
10 Unknown  Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Advair;   Drug: Flovent
11 Completed Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease
Conditions: COPD;   Chronic Obstructive Pulmonary Disease
Interventions: Drug: Roflumilast;   Drug: Placebo
12 Completed Efficacy of Arm Training in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Procedure: comprehensive PR;   Procedure: UEET
13 Not yet recruiting Iron and Chronic Obstructive Pulmonary Disease (COPD) Exercise Trial
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Ferric Carboxymaltose;   Drug: Sodium Chloride 0.9%
14 Recruiting A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Device: Placebo ELLIPTA;   Device: Placebo DISKUS;   Device: Placebo TURBUHALER;   Device: Placebo HANDIHALER;   Other: PQ1;   Other: PQ2;   Other: PQ3;   Other: PQ4
15 Completed Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone propionate/salmeterol powder;   Drug: salmeterol powder
16 Completed Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of Life
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Behavioral: Relaxation Response (instruction, pocket practice card prov);   Behavioral: Mindfulness training using model developed from UMass
17 Completed A Randomized Controlled Trial to Determine Outcome and Cost Effectiveness of Case Management of Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Behavioral: Case Management
18 Completed
Has Results
A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
19 Completed Trial of Vitamin D Supplementation in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Miglyol oil
20 Completed A Trial to Study the Effects of Pulmonary Rehabilitation Program on Exercise Capacity and Quality of Life in Patients With Severe Form of Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Rehabilitation
Intervention: Other: Pulmonary Rehabilitation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.